ELISA kits are commonly used to measure soluble biomarkers across a variety of research areas. ELISA kits for Human DCP can be quantified in various samples, including plasma, serum.
Invitrogen ELISA kits exist in two formats: Uncoated and Coated....ELISA kits are commonly used to measure soluble biomarkers across a variety of research areas. ELISA kits for Human DCP can be quantified in various samples, including plasma, serum.
Invitrogen ELISA kits exist in two formats: Uncoated and Coated. Uncoated ELISA kits...ELISA kits are commonly used to measure soluble biomarkers across a variety of research areas. ELISA kits for Human DCP can be quantified in various samples, including plasma, serum.
Invitrogen ELISA kits exist in two formats: Uncoated and Coated. Uncoated ELISA kits include all the necessary reagents to coat your own plates and run your assay with maximum flexibility. Coated ELISA kits...
ELISA kits are commonly used to measure soluble biomarkers across a variety of research areas. ELISA kits for Human DCP can be quantified in various samples, including plasma, serum.
Invitrogen ELISA kits exist in two formats: Uncoated and Coated. Uncoated ELISA kits include all the necessary reagents to coat your own plates and run your assay with maximum flexibility. Coated ELISA kits are ready-to-use and quality tested for sensitivity, specificity, precision and lot-to-lot consistency.
靶标信息
Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II), also known as des-?-carboxy prothrombin (DCP), is an abnormal form of prothrombin produced primarily by liver tissues under conditions of vitamin K deficiency or antagonism. This immature prothrombin variant lacks sufficient coagulation activity and is prominently overexpressed in hepatocellular carcinoma (HCC) cells, serving as a crucial biomarker for screening and diagnosing HCC. PIVKA-II also appears in some cases of gastric cancer, albeit less frequently. Elevated serum levels of PIVKA-II are not exclusive to malignancies; they can also be seen in non-HCC conditions, which necessitates differential diagnostic strategies. The utility of PIVKA-II is further underscored by its ability to predict extrahepatic metastases in early HCC, supporting its role in comprehensive patient evaluation and monitoring.
同义词
Activation peptide fragment 1; Activation peptide fragment 2; Cf2; Cf-2; coagulation factor 2; coagulation factor II; coagulation factor II (thrombin); coagulation factor II, thrombin; F2; FII; PIVKA-II; prepro-coagulation factor II; Protein Induced by Vitamin K Absence or Antagonist-II; prothrombin; prothrombin B-chain; PT; RPRGL2; serine protease; THPH1; thrombin; Thrombin heavy chain; Thrombin light chain